Nathan M. Appel, PhD, Division of Pharmacotherapies and Medical Consequences of Drug Abuse, National Institute on Drug Abuse, Bethesda, Maryland

Michelle A. Bholat, MD, Department of Family Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California

Ahmed Elkashef, PhD, Division of Pharmacotherapies and Medical Consequences of Drug Abuse, National Institute on Drug Abuse, Bethesda, Maryland

David Farabee, PhD, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California

Annette E. Fleckenstein, PhD, Department of Pharmacology and Toxicology, College of Pharmacy, Salt Lake City, Utah

Suzette Glasner-Edwards, PhD, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California

Glen R. Hanson, DDS, Department of Pharmacology and Toxicology, College of Pharmacy, Salt Lake City, Utah

Angela Hawken, PhD, UCLA Integrated Substance Abuse Programs and Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California

Keith Heinzerling, MD, MPH, Department of Family Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California

Chris-Ellyn Johanson, PhD, Department of Psychiatry and Behavioral Neurosciences, Wayne State University, Chicago, Illinois

William D. King, MD, JD, Department of Family Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California

Evan Landstrom, Department of Family Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California

Sarah Lefkowith, Department of Family Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California

Walter Ling, MD, UCLA Integrated Substance Abuse Programs, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California Edythe D. London, PhD, Neuropsychiatric Institute, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California

Jane C. Maxwell, PhD, Addiction Research Institute, University of Texas at Austin, Austin, Texas

Larissa Mooney, MD, UCLA Integrated Substance Abuse Programs and Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California

Jagoda Pasic, MD, PhD, Department of Psychiatry and Behavioral Sciences, University of Washington at Harborview Medical Center, Seattle, Washington

Doris Payer, BS, Neuropsychiatric Institute, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California

Richard A. Rawson, PhD, UCLA Integrated Substance Abuse Programs, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California

Richard Ries, MD, Department of Psychiatry and Behavioral Sciences, University of Washington at Harborview Medical Center, Seattle, Washington

John M. Roll, PhD, Intercollegiate College of Nursing, Washington State University, Spokane, Washington

Craig R. Rush, PhD, College of Medicine, University of Kentucky, Lexington, Kentucky

Beth A. Rutkowski, MPH, UCLA Integrated Substance Abuse Programs, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California

Charles R. Schuster, PhD, Department of Psychiatry and Behavioral Neurosciences, Wayne State University, Chicago, Illinois

Steven Shoptaw, PhD, Department of Family Medicine, David Geffen School of Medicine, University of California, Los Angeles, California

Sharon Sowell, BA, Department of Clinical Psychology, Washington State University, Spokane, Washington

William W. Stoops, PhD, Department of Behavioral Science, College of Medicine, University of Kentucky, Lexington, Kentucky

Linda J. Thompson, MA, Greater Spokane Substance Abuse Council, Spokane Valley, Washington

Gregory D. Victorianne, BA, Department of Family Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California

Frank J. Vocci, PhD, Friends Research Institute, Baltimore, Maryland

Matthew Worley, BA, Department of Family Medicine, David Geffen School of Medicine, University of California at Los Angeles, Los Angeles, California